loading

Verve Therapeutics Inc 주식(VERV)의 최신 뉴스

pulisher
Dec 19, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Verve Therapeutics, Inc.VERV - The Eastern Progress Online

Dec 19, 2024
pulisher
Dec 19, 2024

Verve Therapeutics Inc Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsVERV - The Eastern Progress Online

Dec 19, 2024
pulisher
Dec 18, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit - The Eastern Progress Online

Dec 18, 2024
pulisher
Dec 18, 2024

2024-12-18 | Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation | NDAQ:VERV | Press Release - Stockhouse Publishing

Dec 18, 2024
pulisher
Dec 18, 2024

Bronstein, Gewirtz & Grossman, LLC Encourages Verve Therapeutics, Inc. (VERV) Investors to Inquire about Securities Investigation - AccessWire

Dec 18, 2024
pulisher
Dec 17, 2024

Verve Therapeutics Slides As Insider Purchases Lose Another US$65k - Yahoo Finance

Dec 17, 2024
pulisher
Dec 16, 2024

Verve Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024VERV - The Eastern Progress Online

Dec 16, 2024
pulisher
Dec 16, 2024

Charles Schwab Investment Management Inc. Increases Stake in Verve Therapeutics, Inc. (NASDAQ:VERV) - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out - AccessWire

Dec 15, 2024
pulisher
Dec 15, 2024

2024-12-15 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Verve Therapeutics, Inc. (VERV) And Encourages Investors to Reach Out | NDAQ:VERV | Press Release - Stockhouse Publishing

Dec 15, 2024
pulisher
Dec 14, 2024

Class Action Filed Against Verve Therapeutics, Inc. (VERV) Seeking Recovery for InvestorsContact The Gross Law Firm - Victoria Advocate

Dec 14, 2024
pulisher
Dec 14, 2024

Verve Therapeutics' SWOT analysis: gene editing firm's stock faces hurdles - Investing.com India

Dec 14, 2024
pulisher
Dec 14, 2024

Verve Therapeutics' SWOT analysis: gene editing firm's stock faces hurdles By Investing.com - Investing.com Australia

Dec 14, 2024
pulisher
Dec 14, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Eastern Progress Online

Dec 14, 2024
pulisher
Dec 14, 2024

Verve Therapeutics, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before October 28, 2024 to Discuss Your RightsVERV - The Eastern Progress Online

Dec 14, 2024
pulisher
Dec 14, 2024

103,348 Shares in Verve Therapeutics, Inc. (NASDAQ:VERV) Purchased by XTX Topco Ltd - MarketBeat

Dec 14, 2024
pulisher
Dec 12, 2024

Pixalate Releases Q3 2024 EMEA Supply-Side Platform (SSP) Market Share Rankings for Connected TV (CTV), Mobile Apps, & Web: Magnite Leads CTV in Germany (65%) on Amazon Fire TV, Verve No. 1 on Mobile (57%) in Google Play Store - GlobeNewswire Inc.

Dec 12, 2024
pulisher
Dec 11, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Verve Therapeutics - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 11, 2024

Shareholders that lost money on Verve Therapeutics, Inc.(VERV) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 11, 2024

Faruqi & Faruqi Reminds Verve Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024VERV - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 11, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm - The Eastern Progress Online

Dec 11, 2024
pulisher
Dec 10, 2024

(VERV) On The My Stocks Page - Stock Traders Daily

Dec 10, 2024
pulisher
Dec 08, 2024

Companies Like Verve Therapeutics (NASDAQ:VERV) Are In A Position To Invest In Growth - Simply Wall St

Dec 08, 2024
pulisher
Dec 06, 2024

VERV SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Verve Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - The Eastern Progress Online

Dec 06, 2024
pulisher
Dec 06, 2024

Jacobs Levy Equity Management Inc. Increases Holdings in Verve Therapeutics, Inc. (NASDAQ:VERV) - MarketBeat

Dec 06, 2024
pulisher
Dec 05, 2024

Redmile Group LLC Sells 80,040 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - MarketBeat

Dec 05, 2024
pulisher
Dec 03, 2024

Verve Therapeutics: Cutting-Edge Science But Highly Risky Stock - Seeking Alpha

Dec 03, 2024
pulisher
Dec 03, 2024

PDT Partners LLC Decreases Position in Verve Therapeutics, Inc. (NASDAQ:VERV) - MarketBeat

Dec 03, 2024
pulisher
Dec 01, 2024

VERV Investors Have Opportunity to Lead Verve Therapeutics, Inc. - GuruFocus.com

Dec 01, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
자본화:     |  볼륨(24시간):